We are live on
!
Find out more
Aristotle Capital Management Portfolio holdings
AUM
$47.8B
1-Year Est. Return
13.38%
This Fund
S&P 500
This Quarter
Est. Return
+8.71%
1 Year Est. Return
+13.38%
3 Year Est. Return
+48.4%
5 Year Est. Return
+59.36%
10 Year Est. Return
+297.67%
AUM
$59B
AUM Growth
+$6.17B
(+12%)
Cap. Flow
+$2.29B
Cap. Flow
% of AUM
3.88%
Top 10 Holdings %
Top 10 Hldgs %
31.71%
Holding
182
New
7
Increased
119
Reduced
29
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Constellation Brands
STZ
|
+$853M |
| 2 |
Oshkosh
OSK
|
+$422M |
| 3 |
Lowe's Companies
LOW
|
+$116M |
| 4 |
Adobe
ADBE
|
+$79.3M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$71.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$628M |
| 2 |
East-West Bancorp
EWBC
|
+$305M |
| 3 |
Penske Automotive Group
PAG
|
+$14.2M |
| 4 |
JPMorgan Chase
JPM
|
+$1.21M |
| 5 |
iShares Global Healthcare ETF
IXJ
|
+$896K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.78% |
| 2 | Financials | 16.84% |
| 3 | Healthcare | 12.46% |
| 4 | Industrials | 12.23% |
| 5 | Materials | 9.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DASTY
51
DELISTED
DASSAULT SYSTEMES SA ADR
DASTY
| $118M | 0.2% |
1,972,139
+65,677
| +3% | +$3.91M |
|
52
Coca-Cola Europacific Partners
CCEP
$48.3B
| $101M | 0.17% |
1,785,997
+96,696
| +6% | +$5.21M |
|
53
ING
ING
$99.8B
| $97.2M | 0.16% |
6,982,640
+210,978
| +3% | +$3.06M |
|
|
NJ
54
DELISTED
NIDEC CP (NIHON KABUSHIKI KAISHA)1 ADS REPTG .25 SH COM STK
NJ
| $93.6M | 0.16% |
3,177,502
+27,757
| +0.9% | +$817K |
|
55
Credicorp
BAP
$31.8B
| $85.4M | 0.14% |
690,265
+35,844
| +5% | +$4.39M |
|
56
Morgan Stanley
MS
$331B
| $81.6M | 0.14% |
831,161
| – | – |
|
57
GSK
GSK
$104B
| $73.3M | 0.12% |
1,330,132
+49,646
| +4% | +$2.58M |
|
|
KUB
58
DELISTED
KUBOTA CORPORATION (ONE ADS REP 5 SHS COM)
KUB
| $72.3M | 0.12% |
649,541
+12,722
| +2% | +$1.42M |
|
|
AKZOY
59
DELISTED
Akzo Nobel NV
AKZOY
| $71.4M | 0.12% |
1,945,855
-7,634
| -0.4% | -$280K |
|
60
Ingersoll Rand
IR
$32.6B
| $61.3M | 0.1% |
+991,030
| New | +$56.4M |
|
61
iShares MSCI EAFE ETF
EFA
$78.4B
| $58.8M | 0.1% |
746,894
+406,210
| +119% | +$32.2M |
|
62
TotalEnergies
TTE
$195B
| $55.8M | 0.09% |
1,128,321
-6,619
| -0.6% | -$329K |
|
63
Unilever
UL
$137B
| $54.6M | 0.09% |
901,859
-11,465
| -1% | -$681K |
|
64
Cameco
CCJ
$37.6B
| $53.1M | 0.09% |
2,433,310
+75,232
| +3% | +$1.82M |
|
|
65
Novartis
NVS
$297B
| $49.2M | 0.08% |
562,209
-7,565,477
| -93% | -$628M |
|
66
Bank of America
BAC
$435B
| $23.8M | 0.04% |
574,416
+82,821
| +17% | +$3.77M |
|
67
Carnival Corporation Ltd
CCL
$38.1B
| $21.4M | 0.04% |
1,065,729
-1,074
| -0.1% | -$23K |
|
68
FirstCash
FCFS
$8.85B
| $16.8M | 0.03% |
243,127
+38,810
| +19% | +$2.98M |
|
69
iShares Russell 1000 Value ETF
IWD
$82.6B
| $14.4M | 0.02% |
85,769
+12,052
| +16% | +$1.97M |
|
70
Axalta
AXTA
$7.66B
| $10.9M | 0.02% |
357,881
+53,424
| +18% | +$1.7M |
|
71
Lennar Class B
LEN.B
$19.4B
| $10.9M | 0.02% |
119,711
+1,056
| +0.9% | +$86.9K |
|
72
Abbott
ABT
$183B
| $10.5M | 0.02% |
74,304
-394
| -0.5% | -$50.4K |
|
73
AbbVie
ABBV
$443B
| $10.2M | 0.02% |
75,400
+11
| +0% | +$1.3K |
|
74
iShares MSCI South Korea ETF
EWY
$23.3B
| $7.74M | 0.01% |
99,378
+2,599
| +3% | +$206K |
|
75
Johnson & Johnson
JNJ
$618B
| $5.85M | 0.01% |
34,200
-247
| -0.7% | -$40.4K |
|
Similar funds
TI
RIM
Aristotle Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Aristotle Capital Management held 182 positions worth $59B, up 12% from $52.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Aristotle Capital Management deployed $2.29B of net new capital in Q4 2021, opening 7 new positions and adding to 119 existing holdings. Its largest new stake was Constellation Brands: 3,741,145 shares worth $939M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Novartis, an estimated $628M trimmed.
- Aristotle Capital Management's largest Q4 2021 buy was Constellation Brands: 3,741,145 shares worth $939M.
- Aristotle Capital Management added most to Oshkosh in Q4 2021, an estimated $422M increase.
- Aristotle Capital Management's biggest Q4 2021 reduction was Novartis, cutting an estimated $628M.
- Aristotle Capital Management fully exited Penske Automotive Group in Q4 2021, selling an estimated $14.2M.
- Aristotle Capital Management's ten largest holdings make up 32% of its $59B portfolio in Q4 2021.
- Aristotle Capital Management opened 7 new positions and closed 5 in Q4 2021.
- Aristotle Capital Management's portfolio value rose 12% quarter-over-quarter to $59B.
Based on Aristotle Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.